Armistice Capital’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.8M Buy
3,264,000
+564,000
+21% +$6.22M 0.37% 42
2026
Q1
$31M Buy
2,700,000
+52,000
+2% +$687K 0.55% 32
2025
Q4
$40.1M Buy
2,648,000
+412,000
+18% +$6.29M 0.48% 32
2025
Q3
$32.7M Sell
2,236,000
-742,000
-25% -$9.74M 0.49% 30
2025
Q2
$33.2M Buy
2,978,000
+14,000
+0.5% +$173K 0.57% 29
2025
Q1
$48.3M Sell
2,964,000
-36,000
-1% -$632K 0.72% 27
2024
Q4
$52.4M Sell
3,000,000
-768,000
-20% -$13.4M 0.71% 28
2024
Q3
$58.9M Buy
3,768,000
+18,000
+0.5% +$288K 0.94% 19
2024
Q2
$49.7M Buy
3,750,000
+50,000
+1% +$685K 0.63% 25
2024
Q1
$53.7M Buy
3,700,000
+100,000
+3% +$1.38M 0.71% 17
2023
Q4
$48.5M Buy
3,600,000
+636,000
+21% +$7.47M 0.66% 29
2023
Q3
$38.1M Buy
2,964,000
+528,000
+22% +$9.5M 0.58% 37
2023
Q2
$44M Buy
2,436,000
+600,000
+33% +$11.2M 0.64% 32
2023
Q1
$30.8M Buy
1,836,000
+1,036,000
+130% +$20.3M 0.44% 46
2022
Q4
$16.4M Buy
+800,000
New +$14.1M 0.29% 59

Other funds holding OFIX

Armistice Capital's OFIX Position: Q2 2026 in Review

Armistice Capital increased its Orthofix Medical (OFIX) stake by 21% in Q2 2026, buying an estimated $6.22M and bringing the position to 3,264,000 shares worth $29.8M. The position accounts for 0.37% of the portfolio, ranked #42.

Armistice Capital first reported a position in OFIX in Q4 2022 and has held it in 15 quarters since. The position peaked at $58.9M in Q3 2024. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • Armistice Capital held 3,264,000 shares of Orthofix Medical worth $29.8M as of Q2 2026.
  • Armistice Capital bought 564,000 Orthofix Medical shares in Q2 2026, an estimated $6.22M.
  • Orthofix Medical made up 0.37% of Armistice Capital's portfolio in Q2 2026, its #42 holding.
  • Armistice Capital first reported a position in Orthofix Medical in Q4 2022 and has held it in 15 quarters since.
  • Armistice Capital's Orthofix Medical position peaked at $58.9M in Q3 2024.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.